Synthesis of 2-(2-aminopyrimidine)-2,2-difluoroethanols as potential bioisosters of salicylidene acylhydrazides

Molecules

Volumn 15, Issue 6, 2010, Pages 4423-4438

  Dahlgren, Markus K ^a   Öberg, Christopher T ^a   Wallin, Erika A ^a   Janson, Pär G ^a   Elofsson, Mikael ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Reformatsky reaction; Salicylidene acylhydrazide; Scaffold hopping; Type III secretion

Indexed keywords

2 AMINOPYRIMIDINE; 2-AMINOPYRIMIDINE; ANTIINFECTIVE AGENT; HYDRAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

ANTI-BACTERIAL AGENTS; HYDRAZINES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PYRIMIDINES;

EID: 77954268482     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15064423     Document Type: Article

References (33)

1. Hueck, C. J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 1998, 62, 379-433.
2. Rasko, D. A.; Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 2010, 9, 117-128.
3. Baron, C. Antivirulence drugs to target bacterial secretion systems. Curr. Opin. Microbiol. 2010, 13, 100-105.
4. Kauppi, A. M.; Nordfelth, R.; Uvell, H.; Wolf-Watz, H.; Elofsson, M. Targeting bacterial virulence: Inhibitors of type III secretion in Yersinia. Chem. Biol. 2003, 10, 241-249. (Pubitemid 36380281)
5. Nordfelth, R.; Kauppi, A. M.; Norberg, H. A.; Wolf-Watz, H.; Elofsson, M. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 2005, 73, 3104-3114.
6. Muschiol, S.; Bailey, L.; Gylfe, A.; Sundin, C.; Hultenby, K.; Bergstrom, S.; Elofsson, M.; Wolf-Watz, H.; Normark, S.; Henriques-Normark, B. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 2006, 103, 14566-14571.
7. Wolf, K.; Betts, H. J.; Chellas-Gery, B.; Hower, S.; Linton, C. N.; Fields, K. A. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 2006, 61, 1543-1555.
8. Bailey, L.; Gylfe, A.; Sundin, C.; Muschiol, S.; Elofsson, M.; Nordstrom, P.; Henriques-Normark, B.; Lugert, R.; Waldenstrom, A.; Wolf-Watz, H.; Bergstrom, S. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett. 2007, 581, 587-595.
9. Slepenkin, A.; Enquist, P. A.; Hagglund, U.; de la Maza, L. M.; Elofsson, M.; Peterson, E. M. Reversal of the antichlaraydial activity of putative type III secretion inhibitors by iron. Infect. Immun. 2007, 75, 3478-3489.
10. Negrea, A.; Bjur, E.; Ygberg, S. E.; Elofsson, M.; Wolf-Watz, H.; Rhen, M. Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 2007, 51, 2867-2876. (Pubitemid 47206224)
11. Hudson, D. L.; Layton, A. N.; Field, T. R.; Bowen, A. J.; Wolf-Watz, H.; Elofsson, M.; Stevens, M. P.; Galyov, E. E. Inhibition of type III secretion in Salmonella enterica serovar typhimurium by small-molecule inhibitors. Antimicrob. Agents. Chemother. 2007, 51, 2631-2635. (Pubitemid 47047354)
12. Veenendaal, A. K. J.; Sundin, C.; Blocker, A. J. Small-molecule type III secretion system inhibitors block assembly of the shigella type III secreton. J. Bacteriol. 2009, 191, 563-570.
13. Tree, J. J.; Wang, D.; McInally, C.; Mahajan, A.; Layton, A.; Houghton, I.; Elofsson, M.; Stevens, M. P.; Gally, D. L.; Roe, A. J. Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7. Infect. Immun. 2009, 77, 4209-4220.
14. Dahlgren, M. K.; Zetterström, C. E.; Gylfe, A.; Linusson, A.; Elofsson, M. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorg. Med. Chem. 2010, 18, 2686-2703.
15. Manvar, A.; Malde, A.; Verma, J.; Virsodia, V.; Mishra, A.; Upadhyay, K.; Acharya, H.; Coutinho, E.; Shah, A. Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides. Eur. J. Med. Chem. 2008, 43, 2395-2403.
16. Yang, H. Y.; Shen, Y.; Chen, J. H.; Jiang, Q. F.; Leng, Y.; Shen, J. H. Structure-based virtual screening for identification of novel 11 beta-HSD1 inhibitors. Eur. J. Med. Chem. 2009, 44, 1167-1171.
17. Liu, W. Y.; Li, H. Y.; Zhao, B. X.; Shin, D. S.; Lian, S.; Miao, J. Y. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells. Carbohydr. Res. 2009, 344, 1270-1275.
18. Vicini, P.; Incerti, M.; La Colla, P.; Loddo, R. Anti-HIV evaluation of benzo[d]isothiazole hydrazones. Eur. J. Med. Chem. 2009, 44, 1801-1807.
19. Mircus, G.; Hagag, S.; Levdansky, E.; Sharon, H.; Shadkchan, Y.; Shalit, I.; Osherov, N. Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant. J. Antimicrob. Chemother. 2009, 64, 755-763.
20. Romeiro, N. C.; Aguirre, G.; Hernandez, P.; Gonzalez, M.; Cerecetto, H.; Aldana, I.; Perez-Silanes, S.; Monge, A.; Barreiro, E. J.; Lima, L. M. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates. Bioorg. Med. Chem. 2009, 17, 641-652.
21. Cosconati, S.; Marinelli, L.; Trotta, R.; Virno, A.; Mayol, L.; Novellino, E.; Olson, A. J.; Randazzo, A. Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders. J. Am. Chem. Soc. 2009, 131, 16336-16337.
22. He, L. Y.; Zhang, L.; Liu, X. F.; Li, X. H.; Zheng, M. Y.; Li, H. L.; Yu, K. Q.; Chen, K. X.; Shen, X.; Jiang, H. L.; Liu, H. Discovering potent inhibitors against the beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Helicobacter pylori: Structure-based design, synthesis, bioassay, and crystal structure determination. J. Med. Chem. 2009, 52, 2465-2481.
23. Patkar, C. G.; Larsen, M.; Owston, M.; Smith, J. L.; Kuhn, R. J. Identification of inhibitors of Yellow fever virus replication using a replicon-based high-throughput assay. Antimicrob. Agents Chemother. 2009, 53, 4103-4114.
24. Marlo, J. E.; Niswender, C. M.; Days, E. L.; Bridges, T. M.; Xiang, Y.; Rodriguez, A. L.; Shirey, J. K.; Brady, A. E.; Nalywajko, T.; Luo, Q.; Austin, C. A.; Williams, M. B.; Kim, K.; Williams, R.; Orton, D.; Brown, H. A.; Lindsley, C. W.; Weaver, C. D.; Conn, P. J. Discovery and characterization of novel allosteric potentiators of M-1 muscarinic receptors reveals multiple modes of activity. Mol. Pharmacol. 2009, 75, 577-588.
25. Patel, V.; Mazitschek, R.; Coleman, B.; Nguyen, C.; Urgaonkar, S.; Cortese, J.; Barker, R. H.; Greenberg, E.; Tang, W. P.; Bradner, J. E.; Schreiber, S. L.; Duraisingh, M. T.; Wirth, D. F.; Clardy, J. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. J. Med. Chem. 2009, 52, 2185-2187.
26. Peterson, Q. P.; Hsu, D. C.; Goode, D. R.; Novotny, C. J.; Totten, R. K.; Hergenrother, P. J. Procaspase-3 activation as an anti-cancer strategy: Structure-activity relationship of procaspaseactivating ompound 1 (PAC-1) and its cellular co-localization with caspase-3. J. Med. Chem. 2009, 52, 5721-5731.
27. MacroModel, version 9.5, Schrödinger LLC, 120 West 45th Street, Tower 45, New York, NY, USA, 10036-4041.
28. SHOP, version 1.0, Molecular Discovery Ltd., 215 Marsh Road, HA5 5NE Pinner, Middlesex, U. K.
29. Bagley, M. C.; Hughes, D. D.; Lubinu, M. C.; Merritt, E. A.; Taylor, P. H.; Tomkinson, N. C. O. Microwave-assisted synthesis of pyrimidine libraries. Qsar Comb. Sci. 2004, 23, 859-867.
30. Iseki, K.; Asada, D.; Kuroki, Y. Preparation of optically active alpha, alpha-difluoro-betahydroxyketones. J. Fluorine Chem. 1999, 97, 85-89.
31. Sato, K.; Tarui, A.; Kita, T.; Ishida, Y.; Tamura, H.; Omote, M.; Ando, A.; Kumadaki, I. Rhodium-catalyzed Reformatsky-type reaction of ethyl bromodifluoroacetate. Tet. Lett. 2004, 45, 5735-5737.
32. Bergmann, R.; Liljefors, T.; Sorensen, M. D.; Zamora, I. SHOP: Receptor-Based Scaffold HOPping by GRID-Based Similarity Searches. J. Chem. Info. Model. 2009, 49, 658-669.
33. Molecular Operating Environment, (MOE), version 2008.10, Chemical Computing Group Inc., Suite 910-1010 Sherbrooke St. W, Montreal, Quebec, Canada H3A 2R7.